Cargando…
FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
INTRODUCTION: Gene amplification is an important mechanism for activating oncogenes in malignant tumors. Although amplification of HER2, C-MYC, CCND1 and FGFR1 has been reported in breast cancers, their role in the progression of in situ to invasive breast carcinoma is unclear. To investigate this q...
Autores principales: | Jang, Min Hye, Kim, Eun Joo, Choi, Yoomi, Lee, Hee Eun, Kim, Yu Jung, Kim, Jee Hyun, Kang, Eunyoung, Kim, Sung-Won, Kim, In Ah, Park, So Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680930/ https://www.ncbi.nlm.nih.gov/pubmed/22863309 http://dx.doi.org/10.1186/bcr3239 |
Ejemplares similares
-
Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
por: Kim, Milim, et al.
Publicado: (2018) -
Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2021) -
Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ
por: Ahn, Hye Shin, et al.
Publicado: (2020) -
Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion
por: Kim, Sun Young, et al.
Publicado: (2017) -
Invasive Cribriform Carcinoma Arising in Malignant Phyllodes Tumor of Breast: A Case Report
por: Choi, Yoomi, et al.
Publicado: (2012)